Apitope raises €12 million in Series B funding
The funds will enable Apitope to progress the clinical development…
29 September 2015 | By Victoria White
The funds will enable Apitope to progress the clinical development of its innovative pipeline which includes therapies for Factor VIII intolerance in Haemophilia A patients...